Ep. 104 - Biotech Shows Support for Ukraine, Plus Latest Intellia Data
BioCentury This Week
00:00
Biote Crisis
A lot of biotes do have some form of operations, sometimes investment and sometimes clinical trials that are going to be effected by this crisis. I wonder if you have any sense of how much of an actual hit to biote companies the folks you spoke with indicated it might have. One is in persuading american and european companies to steer away from conducting clinical research in russia. And then there's the issue of russian money.
Transcript
Play full episode
